Company Analysis

Cingulate Inc. (CING)

Nasdaq: CING · Pharmaceutical Preparations · Kansas City, KS · filing with the SEC since 2021
Grade3.8
◀ Past 3.0● Present 1.8▶ Future 6.0
7 est.

Who runs Cingulate Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Schaffer Shane J.
Chief Executive Officer. First filing Dec 2021, latest Jul 20, 2026, 4 filings in all.
Officers reporting now
7
of 10 people with a filing in the last fifteen months
Directors reporting now
3
19 people on the record since 2021
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Silva Raul R.EVP and CSODec 2021Oct 2, 2026none
Schaffer Shane J.Chief Executive OfficerDec 2021Jul 20, 2026none
Callahan Jennifer L.EVP and CFODec 2021Jul 20, 2026none
Brams MatthewEVP and Chief Medical OfficerDec 2021Jul 20, 2026none
Downey Bryan WadeEVP & Chief Commercial OfficerNov 2025Jul 20, 2026none
Patel Nilay DahyabhaiEVP, CLO and CCOJul 2025Mar 11, 2026none
Myers LaurieEVP and COODec 2021Jul 9, 2025none
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hargroves Thomas JeffreydirectorDec 2021Jul 20, 2026none
Lawrence Bryan JaydirectorFeb 2024Jul 20, 2026none
Werth Peter J.directorDec 2021Jul 20, 2026none
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CING · research, not advice